The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, severe acute respiratory syndrome, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 1 | 2026-06-10 | NCT07640308 | |
| Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study) | Immunity; Yellow Fever Vaccine | Active, not recruiting | Phase 4 | 2023-06-13 | NCT02555072 |